118 related articles for article (PubMed ID: 1326687)
1. Treatment of mycoplasma-contaminated continuous cell lines with mycoplasma removal agent (MRA).
Gignac SM; Uphoff CC; MacLeod RA; Steube K; Voges M; Drexler HG
Leuk Res; 1992 Aug; 16(8):815-22. PubMed ID: 1326687
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mycoplasma contamination in a large panel of cell cultures.
Drexler HG; Gignac SM; Hu ZB; Hopert A; Fleckenstein E; Voges M; Uphoff CC
In Vitro Cell Dev Biol Anim; 1994 May; 30A(5):344-7. PubMed ID: 8069460
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril).
Fleckenstein E; Uphoff CC; Drexler HG
Leukemia; 1994 Aug; 8(8):1424-34. PubMed ID: 7520103
[TBL] [Abstract][Full Text] [Related]
4. Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.
Uphoff CC; Meyer C; Drexler HG
Leukemia; 2002 Feb; 16(2):284-8. PubMed ID: 11840296
[TBL] [Abstract][Full Text] [Related]
5. Comparative antibiotic eradication of mycoplasma infections from continuous cell lines.
Uphoff CC; Drexler HG
In Vitro Cell Dev Biol Anim; 2002 Feb; 38(2):86-9. PubMed ID: 11929000
[TBL] [Abstract][Full Text] [Related]
6. [Elimination of mycoplasmas from cultured human cell lines utilizing a combination of two antibiotics, quinolone and a pleuromutilin derivative].
Mikamo S; Shiroko Y; Hirose I; Sekiguchi M
Hum Cell; 1990 Mar; 3(1):37-44. PubMed ID: 1964584
[TBL] [Abstract][Full Text] [Related]
7. Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics.
Uphoff CC; Gignac SM; Drexler HG
J Immunol Methods; 1992 Apr; 149(1):55-62. PubMed ID: 1316409
[TBL] [Abstract][Full Text] [Related]
8. Elimination of mycoplasmas from cell cultures utilizing hyperimmune sera.
Jeansson S; Brorson JE
Exp Cell Res; 1985 Nov; 161(1):181-8. PubMed ID: 3902490
[TBL] [Abstract][Full Text] [Related]
9. PCR-based detection and eradication of mycoplasmal infections from various mammalian cell lines: a local experience.
Molla Kazemiha V; Shokrgozar MA; Arabestani MR; Shojaei Moghadam M; Azari S; Maleki S; Amanzadeh A; Jeddi Tehrani M; Shokri F
Cytotechnology; 2009 Dec; 61(3):117-24. PubMed ID: 20135349
[TBL] [Abstract][Full Text] [Related]
10. Elimination of mycoplasmas from cell cultures and establishment of mycoplasma-free cell lines.
Schmidt J; Erfle V
Exp Cell Res; 1984 Jun; 152(2):565-70. PubMed ID: 6723803
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the measurement of lysosomal hydrolase activity in mycoplasma-contaminated and non-contaminated human fibroblast cultures treated with mycoplasma removal agent.
Souza FT; Souza Sostruznik L; Casagrande Scolari R; Maciel de Castro KJ; Giugliani R; Coelho JC
Clin Biochem; 2007 May; 40(8):521-5. PubMed ID: 17367773
[TBL] [Abstract][Full Text] [Related]
12. Elimination of mycoplasmas from mouse myeloma cells by intraperitoneal passage in mice and by antibiotic treatment.
Hirschberg L; Bölske G; Holme T
Hybridoma; 1989 Apr; 8(2):249-57. PubMed ID: 2714817
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic sensitivities and elimination of mycoplasmas from infected cell cultures.
Gardella RS; Del Giudice RA
Isr J Med Sci; 1984 Oct; 20(10):931-4. PubMed ID: 6511319
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Mycoplasma contamination from cell lines of different origin by the 5-bromouracil-fluorochrome procedure.
Calorini L; Ruggieri S
Cancer Lett; 1989 Jul; 46(2):107-12. PubMed ID: 2473833
[TBL] [Abstract][Full Text] [Related]
15. A simple method to eliminate mycoplasma from cell cultures.
Coronato S; Vullo D; Coto CE
J Virol Methods; 1994 Jan; 46(1):85-94. PubMed ID: 8175949
[TBL] [Abstract][Full Text] [Related]
16. A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin.
Schmitt K; Däubener W; Bitter-Suermann D; Hadding U
J Immunol Methods; 1988 Apr; 109(1):17-25. PubMed ID: 3282011
[TBL] [Abstract][Full Text] [Related]
17. Culture of Neospora caninum in the presence of a Mycoplasma Removal Agent results in the selection of a mutant population of tachyzoites.
Hudson A; Ellis JT
Parasitology; 2005 Jun; 130(Pt 6):607-10. PubMed ID: 15977896
[TBL] [Abstract][Full Text] [Related]
18. Bioprocess: Robustness with Respect to Mycoplasma Species.
Faison T; Wang J; Johnson S; Brown M; Chiang MJ; Dolan S; Breuning C; Velugula-Yellela SR; Lute S; Fratz-Berilla EJ; Brorson K
PDA J Pharm Sci Technol; 2020; 74(2):201-212. PubMed ID: 31519782
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures.
Nir-Paz R; Prévost MC; Nicolas P; Blanchard A; Wróblewski H
Antimicrob Agents Chemother; 2002 May; 46(5):1218-25. PubMed ID: 11959548
[TBL] [Abstract][Full Text] [Related]
20. [Identification of mycoplasma by the growth inhibition of samples isolated from cell cultures].
Timenetsky J; Miyaki C; Mendes IF; de Rizzo E
Rev Saude Publica; 1992 Feb; 26(1):17-20. PubMed ID: 1307416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
